Development
B
MetLife, Inc. MET
$79.93 $1.371.74% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 24.13% 21.64% 402.50% -94.93% 35.80%
Total Depreciation and Amortization 2,338.46% -13.33% 7.14% -95.21% 1,917.24%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -15.78% 13.58% 35.87% 197.81% -162.87%
Change in Net Operating Assets -- -- -- -- --
Cash from Operations 49.12% 14.38% 49.95% -11.95% -46.61%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 119.38% 53.17% -321.94% -663.45% 95.21%
Cash from Investing 119.38% 53.17% -321.94% -663.45% 95.21%
Total Debt Issued -69.23% 284.84% -72.30% -- -100.00%
Total Debt Repaid 52.53% 34.64% 23.21% 49.63% -463.63%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -8.46% -17.86% 13.85% -30.87% 11.57%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 8.71% -6.50% 5.27% -7.82% 9.05%
Other Financing Activities 229.53% -86.26% 9,266.67% -95.71% -4.64%
Cash from Financing 79.25% -323.75% 116.51% 48.63% -356.34%
Foreign Exchange rate Adjustments 190.63% -45.45% -423.53% -90.53% 224.22%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,234.06% 83.38% -74.76% 13.27% -221.37%